Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research-Reference-Cited by-同舟云学术

Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research

Published:2022 Issue:1 Volume:22 Page:
ISSN:1598-2629
Container-title:Immune Network
language:en
Short-container-title:Immune Netw

Author:

Kim Mingyo¹^ORCID,Choe Yong-ho¹^ORCID,Lee Sang-il¹^ORCID

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju 52727, Korea.

Funder

National Research Foundation of Korea

Korea Health Industry Development Institute

Publisher

The Korean Association of Immunobiologists

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

https://immunenetwork.org/pdf/10.4110/in.2022.22.e8

Reference127 articles.

1. The Pathogenesis of Rheumatoid Arthritis

2. Evolving concepts of rheumatoid arthritis

3. Immunopathogenesis of Rheumatoid Arthritis

4. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes

5. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-rheumatic property and physiological safety of KMU-11342 in in vitro and in vivo models;Inflammation Research;2024-06-15

2. The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients;International Journal of Molecular Sciences;2024-04-16

3. Different modalities to manage rheumatoid arthritis: an A to Z story;Future Science OA;2024-03-20

4. Naturopathic Interventions for Reduction of Perceived Pain in Patients Suffering from Arthritis: A Systematic Review and Meta-Analysis;Cureus;2024-02-20

5. Interleukin-18 Binding Protein (IL-18BP): A Long Journey From Discovery to Clinical Application;Immune Network;2024